{"id":78270,"date":"2026-03-09T12:06:12","date_gmt":"2026-03-09T12:06:12","guid":{"rendered":"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/"},"modified":"2026-03-09T12:06:12","modified_gmt":"2026-03-09T12:06:12","slug":"route-92-medical-enrolls-first-patient-in-summit-rise-study","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/","title":{"rendered":"Route 92 Medical Enrolls First Patient in SUMMIT RISE Study"},"content":{"rendered":"<div>\n<p><em>SUMMIT RISE is expected to enroll up to 500 patients to evaluate the performance of Route 92 Medical\u2019s neurovascular intervention device portfolio<\/em><\/p>\n<p align=\"left\">WEST JORDAN, Utah, March  09, 2026  (GLOBE NEWSWIRE) &#8212; Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced enrollment of the first patient in SUMMIT RISE (NCT07436156), a prospective 500-patient real-world post-clearance study to evaluate the performance of Route 92 Medical\u2019s portfolio of neurovascular interventional solutions across a variety of stroke scenarios and vessel sizes. The study is expected to enroll patients at 50 clinical centers, including academic medical centers and community hospitals.<\/p>\n<p align=\"left\">\u201cWe developed our portfolio of complete neurovascular interventional systems with one goal \u2013 improving outcomes for patients being treated for acute ischemic stroke,\u201d said Tony Chou, M.D., Founder and Chief Executive Officer of Route 92 Medical. \u201cBuilding from our prior studies and trials, including SUMMIT MAX, we expect SUMMIT RISE to give us comprehensive data across anatomies, physician users, devices, patients and clinical sites, enabling us to evaluate and collect wide-ranging data on the family of Route 92 Medical reperfusion systems including the HiPoint 88 reperfusion system, the only FDA-cleared super-bore catheter system for direct aspiration of large vessel occlusions in patients experiencing an acute ischemic stroke.\u201d<\/p>\n<p align=\"left\">SUMMIT RISE is a prospective, multi-center, open-label, core-lab-adjudicated study to assess real-world performance of the Route 92 Medical reperfusion systems that is being led by co-primary investigators Sunil Sheth, M.D., Associate Professor and Director, Vascular Neurology Program at the McGovern Medical School at University of Texas, Houston, Christopher Kelner, M.D., Neurosurgeon at Mt. Sinai Health System, and Albert Yoo, M.D., Medical Director and Director of Research and Technology, Medical City Texas Stroke Institute.<\/p>\n<p align=\"left\">\u201cThe SUMMIT RISE study is designed to collect and analyze data prospectively, and review all cases through an independent adjudication process, to impartially evaluate the effectiveness of Route 92 Medical\u2019s devices across a range of patient presentations, clinician experience levels, and health system settings,\u201d said\u00a0Sunil A.\u00a0Sheth, M.D., Associate Professor of Neurology at UTHealth McGovern Medical School and co-primary investigator of SUMMIT RISE. \u201cWe hope these data elucidate insights that support technique optimization, ultimately improving device performance and patient outcomes.\u201d<\/p>\n<p align=\"left\">\u201cNew medical technologies require rigorous, independently developed, real-world evidence to support their widespread adoption,\u201d said Robert Regenhardt, M.D., Ph.D., Assistant Professor of Neurology at UTHealth McGovern Medical School and the first to enroll a patient in SUMMIT RISE. \u201cThe data we collect in this study will enable the refinement of clinical best practices for stroke treatment.\u201d<\/p>\n<p align=\"left\">For more information about Route 92 Medical\u2019s devices and clinical evidence, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0-VEIfLnC_Dh29_BNmPOLC5YXpNXXjel7tHaR1uvJoKjBSDQcU4P9OLJcmShQu0Vc3hI19kgWr28GYNbUDGH8Q==\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>www.r92m.com<\/u><\/a>.<\/p>\n<p align=\"left\"><strong>About Route 92 Medical, Inc.<\/strong><br \/>Route 92 Medical is on a mission to improve outcomes for patients undergoing neurovascular intervention through cutting-edge engineering and innovative product design. Founded by physicians, the company collaborates with leading neurovascular clinicians to solve the biggest challenges in neurointervention and deliver meaningful, differentiated solutions that promote clinical success. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0-VEIfLnC_Dh29_BNmPOLFY5gBVAkGRwAPMs6daryloswAvdjmd2jsrOIBdeZMwNLfu3hx5rT4NpQajgSIGjTA==\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>www.r92m.com<\/u><\/a> or follow the company on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wS3peRgJppiPT3MwxrM4T19IHg_tQo8U4_DtLAluCAyNuLV_6dHde2eCI53un945aar0ajYPRbbAoAmPaV41pDeyXxpgqK2lMrJaFUuh_Jm0eYGQbcg5y3-BOvR_zWU6rDt_MjiHxpUj-nmn8UYjuGi5btmhATfkzv6Va7xtSZMnEhx_ZuKzcCrInHKdPsvNEb-uMHl8U5xt3tyOptzBCNneDvhYj_YEFS7JbfR1SJCPaNFHireDRI3AYZNbXPNPA-qB6d2sA9j2QWJIxwmTkA==\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>LinkedIn<\/u><\/a>.<\/p>\n<pre>CONTACT: Contacts:\r\n\r\nFor Media\r\nGwen Gordon\r\n858-245-5684\r\ngwen@gwengordonpr.com<\/pre>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MGEzNmQyNTgtOGE3ZS00OWFjLTgzZTQtODVhNmUwNzg4ZGVmLTEyMzY4MzctMjAyNi0wMy0wOS1lbg==\/tiny\/Route-92-Medical-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SUMMIT RISE is expected to enroll up to 500 patients to evaluate the performance of Route 92 Medical\u2019s neurovascular intervention device portfolio WEST JORDAN, Utah, March 09, 2026 (GLOBE NEWSWIRE) &#8212; Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced enrollment of the [&#8230;]\n","protected":false},"author":1,"featured_media":78271,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-78270","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Route 92 Medical Enrolls First Patient in SUMMIT RISE Study - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Route 92 Medical Enrolls First Patient in SUMMIT RISE Study\" \/>\n<meta property=\"og:description\" content=\"SUMMIT RISE is expected to enroll up to 500 patients to evaluate the performance of Route 92 Medical\u2019s neurovascular intervention device portfolio W\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-09T12:06:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml.globenewswire.com\/media\/MGEzNmQyNTgtOGE3ZS00OWFjLTgzZTQtODVhNmUwNzg4ZGVmLTEyMzY4MzctMjAyNi0wMy0wOS1lbg==\/tiny\/Route-92-Medical-Inc-.png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Route 92 Medical Enrolls First Patient in SUMMIT RISE Study\",\"datePublished\":\"2026-03-09T12:06:12+00:00\",\"dateModified\":\"2026-03-09T12:06:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/\"},\"wordCount\":511,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/\",\"name\":\"Route 92 Medical Enrolls First Patient in SUMMIT RISE Study - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2026-03-09T12:06:12+00:00\",\"dateModified\":\"2026-03-09T12:06:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Route 92 Medical Enrolls First Patient in SUMMIT RISE Study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Route 92 Medical Enrolls First Patient in SUMMIT RISE Study - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/","og_locale":"en_US","og_type":"article","og_title":"Route 92 Medical Enrolls First Patient in SUMMIT RISE Study","og_description":"SUMMIT RISE is expected to enroll up to 500 patients to evaluate the performance of Route 92 Medical\u2019s neurovascular intervention device portfolio W","og_url":"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2026-03-09T12:06:12+00:00","og_image":[{"url":"https:\/\/ml.globenewswire.com\/media\/MGEzNmQyNTgtOGE3ZS00OWFjLTgzZTQtODVhNmUwNzg4ZGVmLTEyMzY4MzctMjAyNi0wMy0wOS1lbg==\/tiny\/Route-92-Medical-Inc-.png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Route 92 Medical Enrolls First Patient in SUMMIT RISE Study","datePublished":"2026-03-09T12:06:12+00:00","dateModified":"2026-03-09T12:06:12+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/"},"wordCount":511,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/","url":"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/","name":"Route 92 Medical Enrolls First Patient in SUMMIT RISE Study - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2026-03-09T12:06:12+00:00","dateModified":"2026-03-09T12:06:12+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/route-92-medical-enrolls-first-patient-in-summit-rise-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Route 92 Medical Enrolls First Patient in SUMMIT RISE Study"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/78270","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=78270"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/78270\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/78271"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=78270"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=78270"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=78270"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}